Flor-Essence 7-day Cleanse
Natural health product licensed in Canada
- Other names
- Flor-essence 7-day Purification Program
- Licence holder
- Flora Manufacturing & Distributing Ltd
- NPN or DIN-HM
- 80038661
- Status
- Active licence
- Licence date
- 15 January 2013
- Revision date
- 26 February 2016
- Form
- Kit
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Rheum palmatum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trifolium pratense L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zanthoxylum americanum Source : Écorce | 140 mg | Not calculated |
| Avena sativa Source : Son | 0.2 g | Not calculated |
| Rheum palmatum Source : Racine Extraction ratio : 1:3,000 Dry plant equivalent : 5 mg | 15 mL | Not calculated |
| Arctium lappa Source : Racine Extraction ratio : 1:88 Dry plant equivalent : 171 mg | 15 mL | Not calculated |
| Plantago ovata Source : Enveloppe | 2.3 g | Not calculated |
| Juniperus communis Source : Baie(s) | 70 mg | Not calculated |
| Ulmus rubra Source : Écorce interne | 35 mg | Not calculated |
| Cnicus benedictus Source : Parties aériennes Extraction ratio : 1:1,875 Dry plant equivalent : 8 mg | 15 mL | Not calculated |
| Linum usitatissimum Source : Graine(s) | 2.5 g | Not calculated |
| Rumex acetosella Source : Parties aériennes Extraction ratio : 1:174 Dry plant equivalent : 86 mg | 15 mL | Not calculated |
| Nasturtium officinale Source : Parties aériennes Extraction ratio : 1:1,875 Dry plant equivalent : 8 mg | 15 mL | Not calculated |
| Trifolium pratense Source : Têtes de fleur Extraction ratio : 1:1,875 Dry plant equivalent : 8 mg | 15 mL | Not calculated |
| Arctostaphylos uva-ursi Source : Feuille | 9 mg | Not calculated |
Non-medicinal ingredients
Acid citrique, Kelp, Hypromellose, Eau filtrée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
| Adultes | Not specified | 1 Cuillière(s) à table | 3 Tous les jours |
| Adultes | Not specified | 2 Cuillière(s) à table | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Flor-Essence and Pro-Essence are traditionally used in Herbal Medicine as diuretics. Flor-Essence and Pro-Essence are used in Traditional Herbal Medicine as diaphoretics to induce sweating. Flor-Essence and Pro-Essence are used in Traditional Herbal Medicine as alternatives to help remove accumulated waste products from the body. For-Essence and Pro-Essence are used in Traditional Herbal Medicine as diuretics, diaphoretics and alteratives to help remove accumulated waste products from the body. Floralax II is used as a bulk-forming laxative. Floralax II helps lower bad (LDL) cholesterol.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80038661
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging